U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07007637) titled 'A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa' on May 28.
Brief Summary: This is a study to evaluate the long-term safety, tolerability, and efficacy of sonelokimab in participants with moderate to severe hidradenitis suppurativa who were previously enrolled in a parental study.
Study Start Date: June 13
Study Type: INTERVENTIONAL
Condition:
Hidradenitis Suppurativa
Intervention:
DRUG: Sonelokimab
Sonelokimab
Recruitment Status: NOT_YET_RECRUITING
Sponsor: MoonLake Immunotherapeutics AG
Published by HT Digital...